https://news.alphastreet.com/dermira-suffers-a-fatal-fall-after-catastrophic-trial-fail/ Shares of the skin specialist tanked almost 60% on Monday after the company announced that its closely-watched experimental acne drug failed to meet the objectives of two phase 3 clinical trials.